Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Vevorisertib trihydrochloride | 1416775-08-0 | 99.1% | 696.11 | 1 ML
Supplier: Medchemexpress LLC HY137458A10MM/1ML
Vevorisertib trihydrochloride is a selective, allosteric inhibitor targeting pan-AKT and the AKT1-E17K mutant. It potently inhibits the phosphorylation of AKT, making it a valuable compound for cancer research applications.
- Potently inhibits phosphorylation of AKT
- Selective pan-AKT and AKT1-E17K mutant inhibitor
- Exhibits anti-proliferative effects in various cancer cell lines
- Induces cell cycle arrest and increased cell death when combined with imatinib mesylate
- Demonstrates tumor growth inhibition in mouse xenograft models
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?